<?xml version="1.0" ?>
<document id="5c8e391286fba644689754596eaf50c7f32b5a99">
  <chunk id="5c8e391286fba644689754596eaf50c7f32b5a99.c0" text="Molecular Typing and Epidemiology Profiles of Human Adenovirus Infection among Paediatric Patients with Severe Acute Respiratory Infection in China">
    <entity charOffset="104-110" id="5c8e391286fba644689754596eaf50c7f32b5a99.c0.e0" ontology_id="HP_0012828" text="Severe" type="phenotype"/>
    <entity charOffset="111-116" id="5c8e391286fba644689754596eaf50c7f32b5a99.c0.e1" ontology_id="HP_0011009" text="Acute" type="phenotype"/>
    <entity charOffset="117-138" id="5c8e391286fba644689754596eaf50c7f32b5a99.c0.e2" ontology_id="HP_0011947" text="Respiratory Infection" type="phenotype"/>
  </chunk>
  <chunk id="5c8e391286fba644689754596eaf50c7f32b5a99.c1" text="Human adenoviruses (HAdVs) have been recognised as pathogens that cause a broad spectrum of diseases. The studies on HAdV infection among children with severe acute respiratory infection (SARI) are limited.">
    <entity charOffset="152-158" id="5c8e391286fba644689754596eaf50c7f32b5a99.c1.e0" ontology_id="HP_0012828" text="severe" type="phenotype"/>
    <entity charOffset="159-164" id="5c8e391286fba644689754596eaf50c7f32b5a99.c1.e1" ontology_id="HP_0011009" text="acute" type="phenotype"/>
    <entity charOffset="165-186" id="5c8e391286fba644689754596eaf50c7f32b5a99.c1.e2" ontology_id="HP_0011947" text="respiratory infection" type="phenotype"/>
  </chunk>
  <chunk id="5c8e391286fba644689754596eaf50c7f32b5a99.c2" text="To investigate the prevalence, epidemiology, and genotype of HAdV among children with SARI in China."/>
  <chunk id="5c8e391286fba644689754596eaf50c7f32b5a99.c3" text="Nasopharyngeal aspirates (NPAs) or induced sputum (IS) was collected from hospitalised children with SARIs in Beijing (representing Northern China; n = 259) and Zhejiang Province (representing Eastern China; n = 293) from 2007 to 2010. The prevalence of HAdV was screened by polymerase chain reaction (PCR), followed by sequence typing of PCR fragments that targeted the second half of the hexon gene. In addition, co-infection with other human respiratory viruses, related epidemiological profiles and clinical presentations were investigated."/>
  <chunk id="5c8e391286fba644689754596eaf50c7f32b5a99.c4" text="In total, 76 (13.8%) of 552 SARI patients were positive for HAdV, and the infection rates of HAdV in Northern and Eastern China were 20.1% (n = 52) and 8.2% (n = 24), respectively. HAdV co-infection with other respiratory viruses was frequent (infection rates: Northern China, 90.4%; Eastern China, 70.8%). The peak seasons for HAdV-B infection was winter and spring. Additionally, members of multiple species (Human mastadenovirus B, C, D and PLOS ONE |">
    <entity charOffset="234-242" id="5c8e391286fba644689754596eaf50c7f32b5a99.c4.e0" ontology_id="HP_0040282" text="frequent" type="phenotype"/>
  </chunk>
</document>
